MAHICKRA

Mahickra Chemicals Share Price

₹108.90 +0.9 (0.83%)

21 Nov, 2024 15:50

SIP TrendupStart SIP in MAHICKRA

Start SIP

Performance

  • Low
  • ₹109
  • High
  • ₹109
  • 52 Week Low
  • ₹90
  • 52 Week High
  • ₹159
  • Open Price₹109
  • Previous Close₹108
  • Volume1,500

Investment Returns

  • Over 1 Month -2.33%
  • Over 3 Month + 4.66%
  • Over 6 Month -6.92%
  • Over 1 Year + 10.5%
SIP Lightning

Smart Investing Starts Here Start SIP with Mahickra Chemicals for Steady Growth!

Invest Now

Mahickra Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 89
  • P/B Ratio
  • 2.7
  • Average True Range
  • 8.71
  • EPS
  • 1.32
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.62
  • RSI
  • 50.58
  • MFI
  • 53.2

Mahickra Chemicals Financials

Mahickra Chemicals Technicals

EMA & SMA

Current Price
₹108.90
+ 0.9 (0.83%)
pointer
  • stock-down_img
  • Bullish Moving Average 12
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹107.26
  • 50 Day
  • ₹108.49
  • 100 Day
  • ₹110.31
  • 200 Day
  • ₹108.51

Resistance and Support

105.83 Pivot Speed
  • R3 121.17
  • R2 115.33
  • R1 111.67
  • S1 102.17
  • S2 96.33
  • S3 92.67

What's your outlook on Mahickra Chemicals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mahickra Chemicals has an operating revenue of Rs. 277.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -31% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mahickra Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-24 Quarterly Results
2023-05-15 Audited Results (Revised)
2022-11-10 Quarterly Results (Revised)
2022-02-16 Interim dividend
2021-10-27 Quarterly Results
Date Purpose Remarks
2023-03-03 INTERIM Declared Interim Dividend of 0.65 per equity share.
2022-02-25 INTERIM Declared Interim Dividend of 0.40 per equity share
2021-10-20 INTERIM Declared Interim Dividend of 0.25 per equity share.
2021-03-05 INTERIM Declared Interim Dividend of 0.20 per equity share.

Mahickra Chemicals F&O

Mahickra Chemicals Shareholding Pattern

51.81%
0.59%
36.57%
11.03%

About Mahickra Chemicals

  • NSE Symbol
  • MAHICKRA
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Miteshkumar C Gandhi
  • ISIN
  • INE961Y01015

Similar Stocks to Mahickra Chemicals

Mahickra Chemicals FAQs

Mahickra Chemicals share price is ₹108 As on 21 November, 2024 | 15:36

The Market Cap of Mahickra Chemicals is ₹88.5 Cr As on 21 November, 2024 | 15:36

The P/E ratio of Mahickra Chemicals is As on 21 November, 2024 | 15:36

The PB ratio of Mahickra Chemicals is 2.7 As on 21 November, 2024 | 15:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23